You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Papillary bladder cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-muscle-invasive Bladder Cancer Trial (STM-416)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • (no location specified)
Jan 25, 2023

oncRNA Stratification of Cancer by Size and Stage

Not yet recruiting
  • Kidney Cancer
  • +32 more
  • Exai oncRNA blood test
  • (no location specified)
Apr 27, 2023

Xpert® Bladder Cancer Monitor Test.

Completed
  • Non-Invasive Bladder Urothelial Carcinoma
  • +2 more
  • Xpert® Bladder Cancer Monitor Test
  • Montpellier, Hérault, France
    Clinique Beau Soleil
Feb 8, 2021

Papillary Thyroid Cancer and Central Lymp Node Dissection

Completed
  • Papillary Thyroid Cancer
    • Istanbul, Turkey
      BasaksehirCamSakuraSehirH
    May 15, 2023

    Papillary Thyroid Cancer Trial in Baltimore (Radiofrequency Ablation)

    Active, not recruiting
    • Papillary Thyroid Cancer
    • Radiofrequency Ablation
    • Baltimore, Maryland
      Johns Hopkins Hospital
    Dec 5, 2022

    Oxidative Stress and Mitochondrial TERT in Papillary Thyroid

    Recruiting
    • Papillary Thyroid Cancer
      • Milan, Italy
        Istituto Auxologico Italiano
      Mar 2, 2023

      Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

      Recruiting
      • Non Muscle Invasive Bladder Cancer
      • N803 plus Bacillus Calmette-Guerin (BCG)
      • Honolulu, Hawaii
        Island Urology
      Aug 7, 2023

      Thyroid Cancer, Surgery, Recurrence Trial in Beijing (Thyroxine)

      Recruiting
      • Thyroid Cancer
      • +2 more
      • Beijing, Beijing, China
        Cancer Hospital, Chinese Academy of Medical Science
      Oct 13, 2023

      PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS Trial (blood sampling at inclusion, 6 months, 1 year and 2 years. Tumor

      Not yet recruiting
      • PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS
      • blood sampling at inclusion, 6 months, 1 year and 2 years. Tumor and intracystic fluid samples are taken only if a biopsy is planned following MRI results.
      • (no location specified)
      Aug 17, 2023

      Galectin-3 in Papillary Thyroid Carcinoma

      Not yet recruiting
      • Galactin 3-thyroid Carcinoma
        • (no location specified)
        Jan 26, 2023

        Tumor Deposits for Patients With Papillary Thyroid Carcinoma

        Completed
        • Exploring the Prognostic Value of Tumor Deposits PTC Patients
        • surgery
        • Guangzhou, Guangdong, China
          Nanfang Hospital, Southern Medical University
        Sep 18, 2023

        Papillary Thyroid Carcinoma, Thermal Ablation Trial in Beijing (No Intervention)

        Recruiting
        • Papillary Thyroid Carcinoma
        • Thermal Ablation
        • No Intervention
        • Beijing, China
          Beijing Friendship Hospital
        Jul 19, 2023

        Thyroid Cancer, Recurrence Trial in Beijing (prophylactic central neck dissection)

        Recruiting
        • Thyroid Cancer
        • Recurrence
        • prophylactic central neck dissection
        • Beijing, Beijing, China
          Cancer Hospital, Chinese Academy of Medical Science
        Oct 8, 2023

        A Gene Hunting Study for Familial Papillary Thyroid Cancer

        Recruiting
        • Thyroid
          • Columbus, Ohio
            Ohio State University Comprehensive Cancer Center
          Oct 13, 2022

          Papillary Thyroid Tumors by Mass-ARRAY

          Recruiting
          • Papillary Thyroid Cancer
          • Genotyping
          • Milan, MI, Italy
            Istituto Auxologico Italiano
          Mar 10, 2023

          Association Between Primary Aldosteronism and Thyroid Cancer

          Completed
          • Thyroid Cancer, Papillary
          • Primary Aldosteronism
          • Secreening test for primary aldosteronism and Confirmatory Testing
          • São Paulo, Brazil
            Ana Alice Wolf Maciel
          Oct 3, 2023

          Fascial Versus Standard Neck Dissection in N1b Papillary Thyroid

          Completed
          • Patients With Papillary Thyroid Cancer and N1b Status
          • Fascial Neck Dissection
          • Standard Neck Dissection
          • Rome, Italy
            Fondazione Policlinico Universitario Agostino Gemelli IRCCS
          Mar 27, 2023

          Bladder Carcinoma in Situ (CIS) Trial (ONCOFID P-B (PACLITAXEL-HYALURONIC ACID))

          Recruiting
          • Bladder Carcinoma in Situ (CIS)
          • ONCOFID P-B (PACLITAXEL-HYALURONIC ACID)
          • New Orleans, Louisiana
            Ochsner Clinic Foundation
          Jan 18, 2023

          Non-Invasive Papillary Carcinoma of Bladder Trial in Germany, Italy, Spain (Oncofid-P-B)

          Completed
          • Non-Invasive Papillary Carcinoma of Bladder
          • Essen, Germany
          • +13 more
          Dec 8, 2020

          Concordance of Molecular Classification Based on Fine Needle

          Not yet recruiting
          • Papillary Thyroid Cancer
            • Calgary, Alberta, Canada
              Foothills Medical Centre
            Nov 17, 2023

            Analytical Specificity of Bladder EpiCheck Test in Healthy

            Completed
            • Non Muscle Invasive Bladder Cancer
            • Non-Muscle Invasive Bladder Urothelial Carcinoma
            • Bladder EpiCheck
            • San Antonio, Texas
              Urology San Antonio
            Sep 3, 2023

            Urinary Bladder Tumors Trial run by the NCI (Durvalumab, Vicineum)

            Recruiting
            • Urinary Bladder Neoplasms
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Feb 2, 2023

            Analyzing Urine During BCG Instillation in Bladder Cancer

            Not yet recruiting
            • Bladder Cancer
            • urine sample collection
            • Shanghai, Shanghai, China
              Changhai Hospital
            Nov 30, 2023

            Transitional Cell Carcinoma, Bladder Cancer, Carcinoma in Situ Trial in United States (CG0070 Adenovirus Vector, Control Arm:

            Terminated
            • Transitional Cell Carcinoma
            • +3 more
            • CG0070 Adenovirus Vector
            • Control Arm: Quadruple Choice
            • Phoenix, Arizona
            • +6 more
            Apr 12, 2021

            Patterns of Urinary Bladder Cancer in Darfur, Suda

            Completed
            • Urinary Bladder Cancer
              • Darfur, Sudan
                Nyala specialized hospital
              Nov 27, 2023